Abstract
Brain aging is a physiological event, and oxidative stress and apoptosis are involved in the natural aging process of the brain. Curcumin is a natural antioxidant with potent anti-aging and neuroprotective properties. Therefore, we investigated the protective effects of curcumin on brain apoptosis and oxidative stress, brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF) in aged rats. Old female Wistar rats were randomly divided into three groups (n = 7); as follows: (1) control; (2); saline and (3) curcumin (received 30 mg/kg of curcumin, 5 days/week for 8 weeks, intraperitoneally). Our results indicated that treatment with curcumin in aged rats attenuates brain lipid peroxidation, which was accompanied by a significant increase in the BDNF, VEGF, superoxide dismutase (SOD) activity, and anti-apoptotic protein BCl-2. No significant change in brain anti-apoptotic Bax protein levels was observed after curcumin treatment. The study indicates that curcumin could alleviate brain aging which may be due to attenuating oxidative stress, inhibiting apoptosis, and up-regulating SOD activity, which in turn enhances VEGF and BDNF. Therefore, curcumin has potential therapeutic value in the treatment of neurological apoptosis, neurogenesis, and angiogenesis changes caused by brain aging.
Highlights
Brain aging plays a key role in the development of neurodegenerative diseases.
Oxidative stress is considered one of the main mechanisms of cellular aging.
Brain tissue has relatively low levels of antioxidant enzymes and is more vulnerable to oxidative stress.
During the aging process, apoptosis and susceptibility to apoptosis enhance in several types of intact cells.
Age-related decline in vascular structural integrity and neovascularization capacity occurs throughout the aged brain.
Curcumin, exerts its neuroprotective and anti-aging effects in the aged brain.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Aging is a multifactorial and natural process that is associated with many physiological changes, functional disorders, and behavioral capacity. Brain aging is considered an important aspect of the aging process because it plays a key role in the development of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease (Wu et al. 2014). Aging induces several physiological phenomena in the brain such as a reduction of the number of cerebral nerve cells, deterioration of tissue proteins, tissue atrophy, a slight decrease in the brain size, and reduction of cerebral blood flow (Park and Yeo 2013). Several pathways cause brain aging, but the exact responsible molecular mechanisms are still unknown.
It has been widely found that aging affects both angiogenesis and vascularization (Pineda et al. 2013). Moreover, cerebral neurogenesis decreases with aging, causing a progressive cognitive decline (Gao et al. 2009). Vascular endothelial growth factor (VEGF) exerts both neurogenic and angiogenic functions (Greenberg and Jin 2005). Studies indicate that VEGF-positive cells and microvessel density are decreased in the different brain regions of old rats, and exogenous VEGF may lead to an increase in vascular formation as well as a delay in the aging of the nervous system (Wang et al. 2014). Age-related decline in vascular structural integrity and neovascularization capacity occurs throughout the aged brain, and decreased responsiveness to VEGF is one of the involved mechanisms, possibly due to decreased expression levels of VEGF itself (Watanabe et al. 2020). Oxidative stress is considered one of the main mechanisms of cellular aging. Due to the high concentration of polyunsaturated fatty acids and transition metals in brain tissue, it is very susceptible to oxidative damage (Ionescu-Tucker and Cotman 2021). Reactive oxygen species (ROS) are metabolic byproducts that levels of these oxidative stressors increase gradually with aging, and can lead to irreversible damage to the cytoskeleton and the microtubular network, impairing mitochondrial function and damaging the central nervous system (Molinari et al. 2020; Sechi al. 2015). Additionally, increasing cellular senescence and oxidative stress can cause inflammation, cell membrane damage, and consequently neuronal death (Toricelli et al. 2021). Age-related oxidative brain impairment occurs due to lipid peroxidation products, protein oxidation, and alterations in nuclear and mitochondrial DNA (Castelli et al. 2019). Brain tissue has relatively low levels of antioxidant enzymes and is more vulnerable to ROS compared with other organs (Lee et al. 2020a). The imbalance between pro-oxidant species and antioxidant systems leads to the accumulation of neurotoxic proteins in the brain (Balendra and Singh 2021). Superoxide dismutase (SOD) is an enzymatic endogenous antioxidant, which is made by the body and catalyzes the dismutation of superoxide radicals into hydrogen peroxide (H2O2) and ordinary molecular oxygen (Lee et al. 2020a). It has been reported that SOD deficiency is involved in several neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and stroke (Zhang et al. 2022) and SOD expression exerts an essential role in maintaining cellular redox balance and brain function during aging (Watanabe et al. 2014). Studies have found that normal brain aging was associated with a decreased tendency of SOD in the brain, and the level of lipid peroxidation in the brain was significantly higher in older than that in young rats. The age-related increase in brain lipid peroxidation suggests a role of ROS in the pathogenesis of aging (Haider et al. 2014).
During the aging process, apoptosis and susceptibility to apoptosis are enhanced in several types of intact cells (Higami and Shimokawa 2000). Apoptosis is programmed cell death that in two major regulatory intrinsic and extrinsic pathways induces neuronal death (Toricelli et al. 2021). The B cell leukemia/lymphoma 2(Bcl-2) family can regulate cell death in the central nervous system, and is related to the apoptotic intrinsic pathway (Andreotti et al. 2020). The anti-apoptotic protein Bcl-2 and pro-apoptotic Bcl2 associated X protein (Bax) belong to the Bcl-2 family, which have two distinct functional roles in cell death (Toricelli et al. 2021; Andreotti et al. 2020). The loss of neuronal and glial cell populations is closely associated with dysfunction of the central nervous system (Toricelli et al. 2021) and motor neuron disability in neurodegenerative diseases (Lin and Beal 2006). Apoptosis is traditionally considered an index of brain injury and contributes to various pathological conditions resulting in aging (Wu et al. 2014).
Brain-derived neurotrophic factor (BDNF) is the most important neurotrophin in the brain that performs a neurotrophic function. BDNF exerts its biological actions through tyrosine receptor kinase B and plays a key role in regulating neuronal development, maintenance, survival, and plasticity throughout life (Wu et al. 2014; Waterhouse and Xu 2009). This neurotrophin influences the process of neurogenesis and participates in both structural and functional neuroplasticity (Toricelli et al. 2021). Also, BDNF possesses other neuroprotective effects including anti-apoptosis, anti-oxidation, and suppression of autophagy (Chen et al. 2017). In the brain, BDNF is mainly synthesized in different types of cells and has a crucial role in learning and memory mechanisms (Molinari et al. 2020). Studies have shown that BDNF decreases with normal brain aging and multiple brain disorders, indicating that a disorder of regulation of BDNF signaling is involved BDNF plays a crucial role in mental illness and neurodegenerative diseases including Alzheimer’s disease (Molinari et al. 2020; Hock et al. 2000; Oh et al. 2016). Thus, drugs targeting BDNF signaling may be an effective neuroprotective agent for brain aging as well as neurodegenerative disorders.
It has already been demonstrated in the literature that curcumin, a lipophilic polyphenol compound derived from the rhizome of the plant Curcuma longa can enhance neuroprotection and is one of the most promising anti-aging natural compounds (Vaiserman et al. 2020; Benameur et al. 2021). A previous study has shown that curcumin exerts its neuroprotective and anti-aging effects in aged rat brain regions (Bala et al. 2006) and can cross the blood–brain barrier (Mythri and Bharath 2012). Curcumin has many pharmacological activities, including anti-inflammatory, anti-oxidant, anti-proliferative, and nontoxic (Benameur et al. 2021). Moreover, it has been shown that curcumin, may attenuate D galactose-induced brain aging via regulation of antioxidant enzymes and apoptosis (Lee et al. 2020b). However, the ability of curcumin to improve normal brain aging by mediator factors in angiogenesis and neurogenesis has not been elucidated.
While life expectancy is increasing nowadays, aging is associated with a gradual decline of systemic functioning, especially brain aging is very common among neurodegenerative disorders and dementia (Kandlur et al. 2020). It seems important to increase the focus on understanding the effective mechanisms of compounds with anti-aging properties on brain aging. Therefore, the present study aimed to investigate the protective effect of curcumin on brain apoptosis and oxidative stress, BDNF, and VEGF in aged rats.
Materials and methods
Solvents and drugs
Curcumin, all chemicals, and reagents for biochemical assays were purchased from Sigma Aldrich (USA). Superoxide dismutase (SOD) and TBARS (thiobarbituric acid reactive substances) test kits were purchased from Cayman Chemical Company (Ann Arbor, MI, USA). Assay kits for the measurements of BDNF, VEGF, BCl-2, and Bax were obtained from Cusabio Biotech Co., Ltd., (Wuhan, China).
Animals and administration
Twenty-one healthy female Wistar rats that were 24 months old (body weight: 250–300 g) were purchased from the animal experiment center of Pasteur Institute of Iran and were kept on a 12-hour light-dark cycle at a constant temperature (22 ± 2 °C) and 50% humidity with food and water ad libitum.
After one week of adaptation, the rats were randomly and equally assigned to three groups: (1) the control group received no treatment; (2) the saline group: rats received an intraperitoneal injection (i.p.) of saline (0.9% NaCl) diluted dimethyl sulfoxide (DMSO) and (3) the Curcumin group: rats received 30 mg/kg curcumin (i.p.) dissolved in DMSO for five days per week over eight weeks (Habibian et al. 2016; Ahmadabady et al. 2021). All the animal experimental protocols were approved by the Institutional Animal Ethics Committee of Qaemshahar Branch, Islamic Azad University (IAU. 11,768) and were performed according to the guidelines set out in compliance with the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85 − 23, revised 1985).
Preparation for brain samples
The rats were sacrificed after being anesthetized with a mixture of ketamine (60 mg/kg) and xylazine (5 mg/kg). The brains of the rats were carefully and quickly removed. Samples were homogenized in 0.05 M Tris-HCl buffer with protease inhibitors and then centrifuged at 4000 g for 10 min. The supernatant was conserved at − 80 °C for subsequent experiments.
Biochemical analysis
TBARS, as a marker of lipid peroxidation index, in the brain was measured using a colorimetric assay by thiobarbituric acid (TBA) reagent. Briefly, brain homogenates were incubated with equal volumes of TBA at 90 °C for 10 min. Finally, the mixture was cooled and quantification of the TBARS was determined at 532 nm by comparing the absorption to the standard curve of MDA equivalents generated by acid-catalyzed hydrolysis of 1,1,3,3-tetramethoxypropane and is expressed as nmol/mg protein (El‑Sayed et al. 2022).
The activity of SOD was assessed spectrophotometrically through measuring its ability to inhibit the photochemical reduction of nitrobluetetrazolium (NBT) according to the method described by Sun et al. (1988). Enzyme activity is expressed as unit /mg protein, and one unit SOD is defined as the amount of enzyme required to inhibit the reduction of NBT by 50%.
Statistical analyses
Data were expressed as mean ± standard deviation and analyzed by one-way analysis of variance (ANOVA) followed by the Tukey test post hoc test for multiple comparisons among the groups. Data were analyzed using SPSS software v. 20.0. (IBM, Armonk, NY, USA), and differences were taken to be statistically significant at P < 0.05.
Results
Impact on pro and anti-apoptosis factors
As shown in Table 1, curcumin treatment up-regulated the level of anti-apoptotic protein Bcl-2 and reduced the Bax/Bcl-2 ratio in the brains of aged rats, as compared to the control (22.59%, P = 0.022; 34.69%, P < 0.001, respectively) and saline (24.80%, P = 0.012; 36.00%, P < 0.001, respectively) groups, but had no significant effect on Bax protein.
Impact on lipid peroxidation and SOD activity
Chronic treatment of the curcumin resulted in a significant attenuation in the lipid peroxidation as evidenced by the decreased level of TBARS compared with the control (19.16%, P < 0.001) and saline (19.40%, P < 0.001) groups, whereas; brain SOD activity significantly elevated in the curcumin group compared to the control 20.91%, P < 0.001) and saline (24.84%, P < 0.001) groups (Fig. 1).
Impact on BDNF and VEGF levels
Furthermore, eight weeks of curcumin intervention significantly increased the levels of BDNF and VEGF proteins compared with the respective values in the control (31.70%, P < 0.001; 25.13%, P < 0.001, respectively), saline (29.22%, P < 0.001; 12.34%, P < 0.001, respectively) groups (Fig. 2).
Discussion
The complex structural and molecular processes contribute to brain aging that leads to a balance between protective and degenerative factors. This study examined the neuroprotective effects of curcumin in aged rats, and our results indicated that curcumin administration significantly decreased lipid peroxidation and improved SOD activity in the brain tissue of aged rats, suggesting that curcumin can alleviate oxidative damage in cellular senescence by enhancing the antioxidant capacity in the aging brain process (Habibian et al. 2016; Banji et al. 2014). Oxidative stress is known as one of the most important processes of the aging brain. The brain is an aerobic organ with the highest oxygen consumption rates based on weight and is more susceptible to free radical damage (Haider et al. 2014). Previous studies have shown an elevation in the level of lipid peroxidation in the hippocampus, midbrain, cortex, and cerebellum in rat brains with a reduction in the SOD activity during aging (Samarghandian et al. 2015), and the presence of oxidative stress in aged cells (Kandlur et al. 2020). Curcumin can attenuate brain tissue damage induced by oxidative stress by activating the antioxidant enzymes such as SOD (Habibian et al. 2016; Namgyal et al. 2021). Another study was showed that intraperitoneal administration of curcumin significantly attenuated restraint stress-induced oxidative damage and increased antioxidant defense mechanisms in the rat brain (Samarghandian et al. 2017). Curcumin is one of the potent antioxidants with powerful hydrogen-donating antioxidant activity and triggers the NF-E2 p45-related factor 2(Nrf2) pathway which has a pivotal role in activating antioxidative enzymes. Curcumin is a bioactive polyphenol with anti-aging properties that attenuates age-related cellular damage via a decrease in oxidative stress (Zia et al. 2021).
Our results revealed that chronic curcumin administration in old rats significantly increased the level of BCl-2 protein and decreased the Bax/Bcl-2 ratio in the brain, but was not accompanied by significant changes in the brain Bax protein level. These results suggest that curcumin can have a neuroprotective effect against neuronal apoptosis in old brain tissue by increasing the Bcl-2 anti-apoptotic protein, and failure to change protein Bax pro-apoptotic protein with curcumin treatment may be related to short treatment duration and/or dosage. Animal studies have demonstrated that pro- and anti-apoptosis factors were altered in the aged brain, with increased expression of Bax protein and a decrease in the Bcl-2 protein (Wu et al. 2014; Lee et al. 2020b; Banji et al. 2014; Mao et al. 2007). Moreover, the ratio of Bax to/ Bcl-2 is a crucial factor that determines the cellular response to death stimuli and the progress of cell apoptosis (Wu et al. 2014; Mao et al. 2007) that decreases with the aging brain. It is well established that during aging, increased levels of mitochondrial ROS in aged animals and humans can activate the apoptosis pathway, which is associated with a decrease in the number of functioning cells (Isaev et al. 2018). Similarly, recent studies have also shown that administration of curcumin tended to regulate neuronal loss and suppress apoptosis in the cerebral cortex (Lee et al. 2020b) and brain (El-Far et al. 2021) by down-regulating Bax and increasing Bcl-2 expression through increasing antioxidant enzyme expression (Lee et al. 2020b).
Moreover, our findings also demonstrated that curcumin administration caused an increase in BDNF and VEGF levels in the brains of aged rats. These data provide further insights into the mechanisms underlying the improvement in brain health in normal aging. The up-regulation of VEGF and BDNF which are two key angiogenic and neurogenesis proteins may play a role in healthy brain aging. This is in line with an earlier report showing that oral treatment with curcumin (300 mg/, daily for 3 weeks), increased the levels of BDNF in the hippocampus of D-galactose-induced aged mice (Nam et al. 2014). Franco-Robles et al. (2014) found that curcumin supplementation (50 mg/kg, daily for 8 weeks) improved or restored BDNF levels to normal levels in diabetic db/db mice. Another study has shown that treatment with curcumin significantly reversed the chronic unpredictable stress-induced decreased hippocampal BDNF levels in stressed rats (Liu et al. 2014). These observations confirm that the protective effect of curcumin on the aging brain occurs in part through enhancing the BDNF level, while the effect of curcumin on VEGF levels in the aging brain remains unclear, and it can be considered one of the limitations of this study. Due to the involvement of the VEGF gene family in neuroprotection through multiple biological pathways, conflicting results have been reported for changes in VEGF during brain aging and brain disease. (Mahoney et al. 2021; Shim and Madsen 2018). Accumulated evidence has indicated that the mRNA and protein expression of VEGF is reduced in the hippocampus and cortex of the amyloid beta-injected rats (Guo et al. 2019; Zarezadehmehrizi et al. 2021), and normal aging of the healthy brain is associated whit a decrease in VEGF levels (Shim and Madsen 2018; Villar-Cheda et al. 2009). Curcumin prevents amyloid-β aggregation, and after crossing the blood-brain barrier exerts its protective effect on neurons against toxic insults of aging and amyloid-β (Reddy et al. 2018). It seems that this curcumin’s functional properties are in part related to the up-regulation of VEGF, which counteracts amyloid-β-induced morphological alteration synaptic dysfunction (Martin et al. 2021). It has been reported an age-related decline of VEGF in the brain and cerebral angiogenesis (Viboolvorakul and Patumraj 2014; Rivard et al. 2000) may lead to the inhibition of apoptosis following brain injury (Nag et al. 2019). In addition, elevated cerebrospinal fluid VEGF can improve normal brain aging (Hohman et al. 2015). Both BDNF and VEGF exert angiogenic and neurotrophic effects via binding to their tyrosine kinase receptors such as tropomyosin receptor kinase B (TrkB) and fetal liver kinase-1(Flk-1), respectively. BDNF can stimulate the formation of new vessels by releasing VEGF-mediated angiogenesis (Deyama et al. 2019; Afarid et al. 2020). Furthermore, neurogenesis occurs in proximity to blood vessels with high VEGF expression, and the production and release of BDNF enhance the new vasculature (Chen et al. 2005).
Conclusion
According to the results, it can be delineated that curcumin was effective in ameliorating brain aging. These protective effects may be mediated, at least partly, through reducing oxidative damage, enhancing the Bcl-2 protein, and up-regulating SOD activity, which in turn enhances VEGF and BDNF. These results imply that curcumin could improve age-induced apoptosis, neurogenesis, and angiogenesis changes, and suggest that curcumin has the potential to be used as a potent nutrient for preventing brain aging and age-related diseases. The limitations of this study are the absence of a histological examination of the brain, as well as the evaluation of other indicators of oxidative stress and apoptosis, which can provide more insight into curcumin. Further studies are needed to explore the neuroprotective effect of curcumin for healthy brain aging and to determine the safe dose of curcumin and its optimal administration, especially during aging.
Data Availability
Not applicable.
Abbreviations
- BDNF:
-
Brain-derived neurotrophic factor
- Bax:
-
BCL-2 associated x protein
- Bcl-2:
-
B cell leukemia/lymphoma 2
- DNA:
-
Deoxyribonucleic acid
- H2O2:
-
Hydrogen Peroxide
- Flk-1:
-
Fetal liver kinase-1
- i.p.:
-
Intraperitoneal
- NRF2:
-
NF-E2 p45-related factor 2
- ROS:
-
Reactive oxygen species
- SOD:
-
Superoxide dismutase
- TBARS:
-
Thiobarbituric acid reactive substances
- VEGF:
-
Vascular endothelial growth factor
- TGF-β1:
-
Transforming growth factor β1
- TrkB:
-
Tropomyosin receptor kinase B
References
Afarid M, Namvar E, Sanie-Jahromi F (2020) Diabetic retinopathy and BDNF: A review on its molecular basis and clinical applications. J Ophthalmol 2020: 1602739. https://doi.org/10.1155/2020/1602739
Ahmadabady S, Beheshti F, Shahidpour F, Khordad E, Hosseini M (2021) A protective effect of curcumin on cardiovascular oxidative stress indicators in systemic inflammation induced by lipopolysaccharide in rats. Biochem Biophys Rep 25:100908. https://doi.org/10.1016/j.bbrep.2021.100908
Andreotti DZ, Silva JDN, Matumoto AM, Orellana AM, de Mello PS, Kawamoto EM (2020) Effects of physical exercise on autophagy and apoptosis in aged brain: human and animal studies. Front Nutr 7:94. https://doi.org/10.3389/fnut.2020.00094
Bala K, Tripathy BC, Sharma D (2006) Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology 7:81–89. https://doi.org/10.1007/s10522-006-6495-x
Balendra V, Singh SK (2021) Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer’s Disease. Open Biol 11:210013. https://doi.org/10.1098/rsob.210013
Banji OJ, Banji D, Ch K (2014) Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain. Food Chem Toxicol 74:51–59. https://doi.org/10.1016/j.fct.2014.08.020
Benameur T, Soleti R, Panaro MA, La Torre ME, Monda V, Messina G, Porro C (2021) Curcumin as prospective anti-aging natural compound: Focus on brain. molecules 26: 4794. https://doi.org/10.3390/molecules26164794
Castelli V, Benedetti E, Antonosante A, Catanesi M, Pitari G, Ippoliti R, Cimini A, d’Angelo M (2019) Neuronal cells rearrangement during aging and neurodegenerative Disease: metabolism, oxidative stress and organelles dynamic. Front Mol Neurosci 12:132. https://doi.org/10.3389/fnmol.2019.00132
Chen J, Zhang C, Jiang H, Li Y, Zhang L, Robin A, Katakowski M, Lu M, Chopp M (2005) Atorvastatin induction of VEGF and BDNF promotes brain plasticity after Stroke in mice. J Cereb Blood Flow Metab 25:281–290. https://doi.org/10.1038/sj.jcbfm.9600034
Chen SD, Wu CL, Hwang WC, Yang DI (2017) More insight into BDNF against neurodegeneration: Anti-apoptosis, anti-oxidation, and suppression of autophagy. Int J Mol Sci 18:545. https://doi.org/10.3390/ijms18030545
Deyama S, Bang E, Kato T, Li XY, Duman RS (2019) Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor. Biol Psychiatry 86:143–152. https://doi.org/10.1016/j.biopsych.2018.12.014
El-Far AH, Elewa YHA, Abdelfattah EA, Alsenosy AA, Atta MS, Abou-Zeid KM, Al Jaouni SK, Mousa SA, Noreldin AE (2021) Thymoquinone and curcumin defeat aging-associated oxidative alterations induced by D-Galactose in rats’ brain and heart. Int J Mol Sci 22:6839. https://doi.org/10.3390/ijms22136839
El–Sayed NS, Elatrebi S, Said R, Ibrahim HF, Omar EM (2022) Potential mechanisms underlying the association between type II Diabetes Mellitus and cognitive dysfunction in rats: a link between miRNA–21 and Resveratrol’s neuroprotective action. Metab Brain Dis 37:2375–2388. https://doi.org/10.1007/s11011-022-01035-z
Franco-Robles E, Campos-Cervantes A, Murillo-Ortiz BO, Segovia J, López-Briones S, Vergara P, Pérez-Vázquez V, Solís-Ortiz MS, Ramírez-Emiliano J (2014) Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and Diabetes. Appl Physiol Nutr Metab 39:211–218. https://doi.org/10.1139/apnm-2013-0133
Gao P, Shen F, Gabriel RA, Law D, Yang EY, Yang GY, Young WL, Su H (2009) Attenuation of brain response to vascular endothelial growth factor-mediated angiogenesis and neurogenesis in aged mice. Stroke 403596–403600. https://doi.org/10.1161/STROKEAHA.109.561050
Greenberg DA, Jin K (2005) From angiogenesis to neuropathology. Nature 438:954–959. https://doi.org/10.1038/nature04481
Guo H, Xia D, Liao S, Niu B, Tang J, Hu H, Qian H, Cao B (2019) Vascular endothelial growth factor improves the cognitive decline of Alzheimer’s Disease via concurrently inducing the expression of ADAM10 and reducing the expression of β-site APP cleaving enzyme 1 in Tg2576 mice. Neurosci Res 142:49–57. https://doi.org/10.1016/j.neures.2018.04.003
Habibian M, Moosavi S, Farzanegi P (2016) Regular exercise combined with curcumin supplementation: protective effects against lead- induced cerebellar oxidative damage in an animal model. Neurophysiology 48:17–22. https://doi.org/10.1007/s11062-016-9564-z
Haider S, Saleem S, Perveen T, Tabassum S, Batool Z, Sadir S, Liaquat L, Madiha S (2014) Age-related learning and memory deficits in rats: role of altered brain neurotransmitters, acetylcholinesterase activity and changes in antioxidant defense system. Age (Dordr) 36:9653. https://doi.org/10.1007/s11357-014-9653-0
Higami Y, Shimokawa I (2000) Apoptosis in the aging process. Cell Tissue Res 301:125–132. https://doi.org/10.1007/s004419900156
Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer Disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846–851. https://doi.org/10.1001/archneur.57.6.846
Hohman TJ, Bell SP, Jefferson AL, Alzheimer’s Disease Neuroimaging Initiative (2015) The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer Disease. JAMA Neurol 72:520–529. https://doi.org/10.1001/jamaneurol.2014.4761
Ionescu-Tucker A, Cotman CW (2021) Emerging roles of oxidative stress in brain aging and Alzheimer’s Disease. Neurobiol Aging 107:86–95. https://doi.org/10.1016/j.neurobiolaging.2021.07.014
Isaev NK, Genrikhs EE, Oborina MV, Stelmashook EV (2018) Accelerated aging and aging process in the brain. Rev Neurosci 29:233–240. https://doi.org/10.1515/revneuro-2017-0051
Kandlur A, Satyamoorthy K, Gangadharan G (2020) Oxidative stress in cognitive and epigenetic aging: a retrospective glance. Front Mol Neurosci 202013:41. https://doi.org/10.3389/fnmol.2020.00041
Lee KH, Cha M, Lee BH (2020a) Neuroprotective effect of entioxidants in the brain. Int J Mol Sci 21:7152. https://doi.org/10.3390/ijms21197152
Lee J, Kim YS, Kim E, Kim Y, Kim Y (2020b) Curcumin and hesperetin attenuate D-galactose-induced brain senescence in vitro and in vivo. Nutr Res Pract 14:438–452. https://doi.org/10.4162/nrp.2020.14.5.438
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative Diseases. Nature 443:787–795. https://doi.org/10.1038/nature05292
Liu D, Wang Z, Gao Z, Xie K, Zhang Q, Jiang H, Pang Q (2014) Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress. Behav Brain Res 271:116–121. https://doi.org/10.1016/j.bbr.2014.05.068
Mahoney ER, Dumitrescu L, Moore AM, Cambronero FE, De Jager PL, Koran MEI, Petyuk VA, Robinson RAS, Goyal S, Schneider JA, Bennett DA, Jefferson AL, Hohman TJ (2021) Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s Disease. Mol Psychiatry 26:888–896. https://doi.org/10.1038/s41380-019-0458-5
Mao Z, Zheng YL, Zhang YQ, Han BP, Zhu XW, Chang Q, Hu XB (2007) The anti-apoptosis effects of daidzein in the brain of D-galactose treated mice. Molecules 12:1455–1470. https://doi.org/10.3390/12071455
Martin L, Bouvet P, Chounlamountri N, Watrin C, Besançon R, Pinatel D, Meyronet D, Honnorat J, Buisson A, Salin PA, Meissirel C (2021) VEGF counteracts amyloid-β-induced synaptic dysfunction. Cell Rep 35:109121. https://doi.org/10.1016/j.celrep.2021.109121
Molinari C, Morsanuto V, Ruga S, Notte F, Farghali M, Galla R, Uberti F (2020) The role of BDNF on aging-modulation markers. Brain Sci 10:285. https://doi.org/10.3390/brainsci10050285
Mythri RB, Bharath MM (2012) Curcumin: a potential neuroprotective agent in Parkinson’s Disease. Curr Pharm Des 18:91–99. https://doi.org/10.2174/138161212798918995
Nag S, Manias J, Eubanks JH, Stewart DJ (2019) Increased expression of vascular endothelial growth factor-D following brain injury. Int J Mol Sci 20:1594. https://doi.org/10.3390/ijms2007159
Nam SM, Choi JH, Yoo DY, Kim W, Jung HY, Kim JW, Yoo M, Lee S, Kim CJ, Yoon YS, Hwang IK (2014) Effects of curcumin (Curcuma longa) on learning and spatial memory as well as cell proliferation and neuroblast differentiation in adult and aged mice by upregulating brain-derived neurotrophi. J Med Food 17:641–649. https://doi.org/10.1089/jmf.2013.2965
Namgyal D, Ali S, Hussain MD, Kazi M, Ahmad A, Sarwa M (2021) Curcumin ameliorates the Cd-induced anxiety-like behavior in mice by regulating oxidative stress and neuro-inflammatory proteins in the prefrontal cortex region of the brain. Antioxid (Basel) 10:1710. https://doi.org/10.3390/antiox10111710
Oh H, Lewis DA, Sibille E (2016) The role of BDNF in age-dependent changes of excitatory and inhibitory synaptic markers in the human prefrontal cortex. Neuropsychopharmacology 41:3080–3091. https://doi.org/10.1038/npp.2016.126
Park DC, Yeo SG (2013) Aging Korean J Audiol 17:39–44. https://
Pineda JR, Daynac M, Chicheportiche A, Cebrian-Silla A, Sii Felice K, Garcia-Verdugo JM, Boussin FD, Mouthon MA (2013) Vascular-derived TGF-β increases in the stem cell niche and perturbs neurogenesis during aging and following irradiation in the adult mouse brain. EMBO Mol Med 5:548–562. https://doi.org/10.1002/emmm.201202197
Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Tonk S, Kuruva CS, Bhatti JS, Kandimalla R, Vijayan M, Kumar S, Wang R, Pradeepkiran JA, Ogunmokun G, Thamarai K, Quesada K, Boles A, Reddy AP (2018) Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s Disease. J Alzheimers Dis 61:843–866. https://doi.org/10.3233/JAD-170512
Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D, Semenza GL, Isner JM (2000) Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 275:29643–29647. https://doi.org/10.1074/jbc.M001029200
Samarghandian S, Azimi-Nezhad M, Samini F (2015) Preventive effect of safranal against oxidative damage in aged male rat brain. Exp Anim 64:65–71. https://doi.org/10.1538/expanim.14-0027
Samarghandiana S, Azimi-Nezhad M, Farkhondehc T, Saminid F (2017) Anti-oxidative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney. Biomed Pharmacother 87:223–229. https://doi.org/10.1016/j.biopha.2016.12.105
Sechi S, Chiavolelli F, Spissu N, Di Cerbo A, Canello S, Guidetti G (2015) An antioxidant dietary supplement improves brain-derived neurotrophic factor levels in serum of aged dogs: preliminary results. J Vet Med 2015:412501. https://doi.org/10.1155/2015/412501
Shim JW, Madsen JR (2018) VEGF signaling in neurological disorders. Int J Mol Sci 19:275. https://doi.org/10.3390/ijms19010275
Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500
Toricelli M, Pereira AAR, Souza Abrao G, Malerba HN, Maia J, Buck HS (2021) Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process. Neural Regen Res 16:58–67. https://doi.org/10.4103/1673-5374.286952
Vaiserman A, Koliada A, Zayachkivska A, Lushchakc O (2020) Curcumin: A therapeutic potential in ageing-related disorders. Pharma Nutrition 144:100226. https://doi.org/10.1016/j.phanu.2020.100226
Viboolvorakul S, Patumraj S (2014) Exercise training could improve age-related changes in cerebral blood flow and capillary vascularity through the upregulation of VEGF and eNOS. Biomed Res Int 2014:230791. https://doi.org/10.1155/2014/230791
Villar-Cheda B, Sousa-Ribeiro D, Rodriguez-Pallares J, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2009) Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson’s Disease. J Cereb Blood Flow Metab 29:230–234. https://doi.org/10.1038/jcbfm.2008.127
Wang H, Ren B, Li Z, Wu H, Zhang G, Yan P (2014) Expression of vascular endothelial growth factor and microvessel density in different brain regions in aged rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 39:681–686. https://doi.org/10.11817/j.issn.1672-7347.2014.07.005
Watanabe K, Shibuya S, Ozawa Y, Nojiri H, Izuo N, Yokote K, Shimizu T (2014) Superoxide dismutase 1 loss disturbs intracellular redox signaling, resulting in global age-related pathological changes. Biomed Res Int 140165:1–10. https://doi.org/10.1155/2014/140165
Watanabe C, Imaizumi T, Kawai H, Suda K, Honma Y, Ichihashi M, Ema M, Mizutani KI (2020) Aging of the vascular system and neural Diseases. Front Aging Neurosci 12:557384. https://doi.org/10.3389/fnagi.2020.557384
Waterhouse EG, Xu B (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 42:81–89. https://doi.org/10.1016/j.mcn.2009.06.009
Wu W, Wang X, Xiang Q, Meng X, Peng Y, Du N, Liu Z, Sun Q, Wang C, Liu X (2014) Astaxanthin alleviates brain aging in rats by attenuating oxidative stress and increasing BDNF levels. Food Funct 5:158 – 66. https://doi.org/10.1039/c3fo60400d. PMID: 24326685
Zarezadehmehrizi A, Hong J, Lee J, Rajabi H, Gharakhanlu R, Naghdi N, Azimi M, Park Y (2021) Exercise training ameliorates cognitive dysfunction in amyloid beta-injected rat model: possible mechanisms of Angiostatin/VEGF signaling. Metab Brain Dis 36:2263–2271. https://doi.org/10.1007/s11011-021-00751-2
Zhang MS, Liang JH, Yang MJ, Ren YR, Cheng DH, Wu QH, He Y, Yin J (2022) Low serum superoxide dismutase is associated with a high risk of cognitive impairment after mild acute ischemic Stroke. Front Aging Neurosci 14:834114. https://doi.org/10.3389/fnagi.2022.834114
Zia A, Pourbagher-Shahri AM, Farkhondeh T, Samarghandian S (2021) Molecular and cellular pathways contributing to brain aging. Behav Brain Funct 17:6. https://doi.org/10.1186/s12993-021-00179-9
Acknowledgements
Thanks to the vice chancellor of research of Islamic Azad University, Qaemshahar Branch, Qaemshahar, Iran.
Funding
A Part of this project was supported by Qaemshahar Branch, Islamic Azad University, Qaemshahar, Iran (project grant no. 1/15424).
Author information
Authors and Affiliations
Contributions
All authors equally contributed to preparing all parts of the research and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
All the animal experimental protocols were approved by the Institutional Animal Ethics Committee of Qaemshahar Branch, Islamic Azad University (IAU. 11768) and were performed in accordance with the guidelines set out in compliance with the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85 − 23, revised 1985).
Consent to participate
All participants signed a written informed consent before enrolment after explaining the importance of this study.
Consent for publication
Not applicable.
Competing interests
The authors have no relevant financial or nonfinancial interests to disclose.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cheriki, M., Habibian, M. & Moosavi, S.J. Curcumin attenuates brain aging by reducing apoptosis and oxidative stress. Metab Brain Dis 39, 833–840 (2024). https://doi.org/10.1007/s11011-023-01326-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-023-01326-z